 SAN FRANCISCO and CAMBRIDGE, Mass., June 17, 2021 GLOBE NEWSWIRE -- FibroGen, Inc. Nasdaq: FGEN and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune modulation and single cell science announced a partnership covering three HiFiBiO programs. 